A lot of things could have caused the price to jump today.

New Post Public Reply Private Reply Replies (1) Message Board
joey68 Pugilista #238
A lot of things could have caused the price to jump today. talking about share price actually has nothing to do with what the company is worth.

Quote:

That being said, the principal theory is that the price movement of a stock indicates what investors feel a company is worth. Don't equate a company's value with the stock price. The value of a company is its market capitalization, which is the stock price multiplied by the number of shares outstanding. For example, a company that trades at $100 per share and has 1 million shares outstanding has a lesser value than a company that trades at $50 that has 5 million shares outstanding ($100 x 1 million = $100 million while $50 x 5 million = $250 million). To further complicate things, the price of a stock doesn't only reflect a company's current value, it also reflects the growth that investors expect in the future.


http://www.investopedia.com/university/stocks/stocks4.asp

I believe the quote below sums it up:

Quote:
it is investors' sentiments, attitudes and expectations that ultimately affect stock prices.


SCIE, in my opinion is grossly undervalued . Several weeks ago I posted about another company (LOG$) which has no product, never had a product, and probably never will; yet their PPS went to 30 CENTS only two weeks ago. Its insane!

Could you image how rich we'd be if SCIE was at .30 cents right now?? And SCIE HAS a product! I think investor sentiment is on the rise; finally beginning to see SCIE for what it is - a real company, with a real CEO, with a real product that actually works. If SCIE had continual sales, what would honestly be keeping them from reaching .50 cents? Nothing in my opinion.

My personal opinion as to what happened today? Insider trading. GASP! no, not the bad illegal kind; theres actually a legal side to insider trading which many people tend to forget about or ignore because its not dramatic enough to talk about in posts.

This sums it up:
http://www.investopedia.com/articles/02/061202.asp

For new investors, its a a good read.

This is a great sentence:

Quote:
The SEC considers insiders to be company directors, officials or any individual with a stake of 10% or more in the company. Insiders are required to report their insider transactions within two business days of the date the transaction occurred (before the 2002 Sarbanes-Oxley Act it used to be the 10th day of the following month). For example, if an insider sold 10,000 shares on Monday, June 12, he or she would have to report this change by Wednesday, June 14. Changes in insider holdings are sent to the SEC electronically as a Form 4, which details a company's insider trades or loans. The following link is an example of a Form 4 filed by the CEO of Krispy Kreme Doughnuts. A Form 14a, also filed by the company, lists all the directors and officers along with the share interest they have.


Of course, this may not be the case with SCIE. Perhaps no insider trading occurred (the legal kind). But if it did, guess what? If it did, we would see a SEC filing this Friday at the earliest. And if that happens, it would be great for us. If it doesn't happen, that's fine too; it simply means this post doesn't relate to SCIE this time. Of course, with the SEC, there are always exceptions to the rules, so don't go crying if/when no SEC filing doesn't show up by Friday.

An even better sentence...

Quote:
This kind of information is extremely valuable to individual investors. For example, if insiders are buying shares in their own companies, they usually know something that normal investors do not. They might buy because they see great potential, a merger, acquisition or simply because they think their stock is undervalued.

So, if someone inside SCIE knows something we don't about the recent oncoscope merger... the spike in PPS might be related to that as well.


This post might be completely wrong about todays price action, but it does give reason as to why price change may occur. Time will tell.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 248

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 485

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Inter Miami CF: New Era's Champions Collection Launch

Updated Category News Views 246

New Era Launches 2025 MLS Champions Collection In an exciting move for soccer enthusiasts, New Era has announced its 2025 MLS Champions Collection, dedicated to celebrating the remarkable achievements of Inter Miami CF. As the official On-Field Cap partner of Major League Soccer (MLS), New Era has taken this opportunity to honor the victorious spirit of Inter Miami. A...

Continue Reading
Birkenstock's Growth Projections are Set to Surge in 2025

Updated Category News Views 368

Birkenstock's Revenue Outlook for 2025 Birkenstock Holding plc (NYSE: BIRK) recently saw its shares rise significantly as the iconic footwear company reiterated its optimistic outlook for the upcoming fiscal year. The company's executives have announced expectations for a revenue of at least 2.09 billion euros, which translates to approximately $2.25 billion for fiscal...

Continue Reading
Fermi's Board Drama: Neugebauer's Play for Change

Updated Category News Views 55

Two Women, One Baby: The Fermi Saga Boils Over Crack open the newspapers, folks, because Toby Neugebauer’s campaign against Fermi's board reads like high-stakes drama right out of Dallas. He’s practically drawing parallels to King Solomon’s story—two women, one baby. This Corporation ain't no nursery though—it's a high-stakes boardroom battle with Neugebauer...

Continue Reading
Understanding U.S. Housing Shortage Through Neighborhood Analysis

Updated Category News Views 396

New Insights on Housing Supply and Demand Recent data indicates a national shortage of approximately two million housing units, revealing significant gaps in middle-income neighborhoods while wealthier areas may have surpluses. The analysis unveils critical disparities that demand urgent attention and action from policymakers. Neighborhood-Level Analysis of Housing...

Continue Reading
Truist's Commitment of $725 Million for Community Recovery

Updated Category News Views 328

Truist's Major Initiative for Community Support Truist Financial Corporation (NYSE: TFC) has unveiled a transformative plan aimed at driving recovery and enhancing community resilience. The initiative, known as Truist Cares, will dedicate an impressive $725 million over three years to support various critical areas. Focus Areas of the Initiative The resources raised...

Continue Reading